Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Healthcare's high-stakes courtroom battles
drug costs
Fierce Pharma
PhRMA pushes back on CMS' Part B MFN model in court
As the Trump administration advances plans to bring its “most favored nation” drug pricing model to Medicare Part B, PhRMA is pushing back in court.
Fraiser Kansteiner
Oct 8, 2026 8:05am
HRSA taps Pfizer, AbbVie, others for revised 340B rebate pilot
Oct 2, 2026 1:00pm
Fierce Pharma
White House unveils next round of MFN drug pricing deals
Aug 31, 2026 5:10pm
Fierce Pharma
PhRMA's Medicare price negotiation appeal sputters out
Aug 27, 2026 10:42am
Revised 340B Rebate Model Pilot Program moves forward
Jul 31, 2026 1:15pm
Inflation grows for hospital supply chains in 2027: Vizient
Jul 29, 2026 12:00pm